Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand disease. 1989

P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
A Bianchi Bonomi Hemophilia and Thrombosis Center, University of Milan, Italy.

To characterize the heterogeneity of severe (type III) von Willebrand disease (vWD), plasma and platelet von Willebrand factor antigen (vWF:Ag) and ristocetin cofactor activity (Ricof) were measured in 28 obligatory heterozygotes (ie, parents or children of probands from 15 different kindreds with severe vWD). On the average, heterozygotes had low levels of vWF in both platelets and plasma. There was, however, considerable heterogeneity, with four distinct patterns. Eleven heterozygotes had concordant reduction of vWF:Ag and Ricof in both plasma and platelets; five had low levels of vWF:Ag and Ricof in plasma contrasting with normal levels in platelets; eight had a peculiar pattern, the reverse of the above (ie, low levels in platelets and normal levels in plasma); and in one, both vWF measurements were normal in plasma and platelets. These patterns were genetically determined: they were consistent in four couples of consanguineous heterozygotes and in two couples carrying the same gene deletion. Only the remaining three heterozygotes had no clearly identifiable pattern. Other findings of this study were that although most of the heterozygotes had normal bleeding times, the 7 of 28 who had prolonged bleeding times had concordantly low levels of vWF measurements in both plasma and platelets. In conclusion, this large series of obligatory heterozygotes provides evidence for phenotypic and genotypic heterogeneity of severe vWD.

UI MeSH Term Description Entries
D001760 Bleeding Time Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. Aspirin Tolerance Test,Bleeding Time, Template,Duke Method,Ivy Method,Template Bleeding Time,Aspirin Tolerance Tests,Bleeding Times,Bleeding Times, Template,Method, Duke,Method, Ivy,Template Bleeding Times,Test, Aspirin Tolerance,Tests, Aspirin Tolerance,Time, Bleeding,Time, Template Bleeding,Times, Bleeding,Times, Template Bleeding,Tolerance Test, Aspirin,Tolerance Tests, Aspirin
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012310 Ristocetin An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro. Ristomycin
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias

Related Publications

P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
June 1985, Thrombosis research,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
July 2017, Journal of thrombosis and haemostasis : JTH,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
May 1986, American journal of hematology,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
July 1989, American journal of hematology,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
October 1986, Thrombosis research,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
January 2016, PloS one,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
October 1989, The American journal of medicine,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
December 1988, The American journal of medicine,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
November 1987, Thrombosis research,
P M Mannucci, and A Lattuada, and G Castaman, and R Lombardi, and M L Colibretti, and N Ciavarella, and F Rodeghiero
June 1998, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
Copied contents to your clipboard!